| Catalog No. |
TD-JN067016 |
| Species reactivity |
P. aeruginosa |
| Applications |
Research Grade Biosimilar |
| Host species |
Human |
| Isotype |
IgM-kappa |
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
LPS |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G, purified from cell culture supernatant. |
| Form |
Liquid |
| Storage buffer |
0.01M PBS,pH7.4. |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names |
Lambrolizumab,Aerumab11,KBPA101,CAS:885053-97-4 |
| Background |
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa. |
| Note |
For research use only. Not for use in clinical or therapeutic applications. |
抗体
试剂盒
多肽
蛋白
组织芯片
定制服务咨询